🟩 9/10일자 벨기에 계약 소식

유럽연합의 온라인 조달관보인 TED(Tenders Electronic Daily)에서 9/10일자 벨기에 계약 낙찰 공고가 1건 확인되네요

⬛️ 543455-2024 - Result : 벨기에

약품명은Trastuzumab IV(허쥬마) & Rituximab IV(트룩시마)로 확인됩니다. 낙찰금액은 2건, 187,181,00eur 2억8천정도로 확인되며 계약일자는 8/14일입니다. 낙찰금액을떠나 벨기에에서 계속해서 항암제 낙찰 소식이 들려오네요~

자세한 내용은 첨부 및 아래내용을 참고하세요

⬛️ Results ---------------------------------

LOT-0001: Trastuzumab IV - 허쥬마 낙찰

LOT-0002: Rituximab IV - 트룩시마 낙찰

■ LOT-0001: At least one winner was chosen.

Maximum value of the framework agreement: 113 003,00 EUR

Tender identifier: Celltrion Healthcare Netherlands BV

Identifier of lot or group of lots: LOT-0001

□ Value of the tender: 71 053,58 EUR

Identifier of the contract: 3512-3712

□ Trastuzumab IV

□ Date of the conclusion of the contract: 14/08/2024

□ Winner: Celltrion Healthcare Netherlands BV

■ LOT-0002: At least one winner was chosen.

Maximum value of the framework agreement: 244 480,00 EUR

Tender identifier: Celltrion Healthcare Netherlands BV

Identifier of lot or group of lots: LOT-0002

□ Value of the tender: 116 128,00 EUR

Identifier of the contract: 3514-3714

□ Rituximab IV

□ Date of the conclusion of the contract: 14/08/2024

□ Winner: Celltrion Healthcare Netherlands BV

□ 최근 벨기에 계약소식

https://band.us/band/88457085/post/42412

https://band.us/band/88457085/post/42170